Hana M El Sahly Selected Research

Hana M El Sahly Research Topics

Disease

30	COVID-19 04/2024 - 01/2021
11	Infections 10/2023 - 05/2013
10	Human Influenza (Influenza) 07/2023 - 08/2008
3	Zika Virus Infection 01/2023 - 01/2019
2	Influenza in Birds (Avian Flu) 07/2023 - 12/2020
2	Breakthrough Infections 01/2022 - 10/2021
2	Dengue (Dengue Fever) 01/2021 - 01/2019
2	Tuberculosis (Tuberculoses) 08/2011 - 01/2004
1	Substance-Related Disorders (Drug Abuse) 11/2023
1	Schistosomiasis mansoni 01/2023
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2023
1	Abdominal Pain (Pain, Abdominal) 01/2023
1	Disease Progression 07/2022
1	Severe Acute Respiratory Syndrome 01/2022
1	Asymptomatic Infections 11/2021
1	Viremia 01/2019
1	Tularemia 01/2017
1	Vaccinia 01/2017
1	Headache (Headaches) 01/2017
1	Anthrax 10/2014
1	Pain (Aches) 10/2011
1	Erythema Infectiosum (Fifth Disease) 10/2011
1	Injection Site Reaction 10/2011
1	Pleural Effusion (Pleural Effusions) 07/2006
1	Lung Diseases (Lung Disease) 07/2006

Drug/Important Bio-Agent (IBA)

35	VaccinesIBA 11/2023 - 08/2008
16	2019-nCoV Vaccine mRNA-1273IBA 07/2023 - 01/2021
9	COVID-19 VaccinesIBA 04/2024 - 10/2021
6	Neutralizing AntibodiesIBA 12/2023 - 01/2019
5	Messenger RNA (mRNA)IBA 07/2023 - 01/2021
4	BNT162 VaccineIBA 07/2023 - 10/2021
4	AntibodiesIBA 01/2023 - 01/2019
3	Proteins (Proteins, Gene)FDA Link 07/2023 - 01/2021
3	Ad26COVS1IBA 07/2023 - 10/2021
3	Immunoglobulin G (IgG)IBA 01/2023 - 01/2019
3	baricitinibIBA 07/2022 - 01/2021
3	remdesivirIBA 07/2022 - 01/2021
3	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2019
2	Viral RNAIBA 04/2024 - 01/2019
2	NVX-CoV2373 adjuvated lipid nanoparticleIBA 10/2023 - 07/2023
2	Monoclonal AntibodiesIBA 01/2023 - 01/2023
2	mRNA VaccinesIBA 07/2022 - 01/2022
2	Oxygen (Dioxygen)IBA 01/2022 - 01/2021
2	MF59 oil emulsionIBA 01/2021 - 10/2011
2	Hemagglutinins (Hemagglutinin)IBA 01/2019 - 04/2010
1	Antiviral Agents (Antivirals)IBA 04/2024
1	AntigensIBA 04/2024
1	Biomarkers (Surrogate Marker)IBA 04/2024
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2023
1	casirivimab and imdevimab drug combinationIBA 01/2023
1	ProcalcitoninIBA 01/2023
1	Formaldehyde (Formol)FDA Link 01/2023
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2023
1	N-(2-cyanoethylene)urea (BA 1)IBA 07/2022
1	Dihydrotachysterol (AT 10)IBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	Imiquimod (Aldara)FDA LinkGeneric 11/2021
1	Lipid NanoparticlesIBA 01/2021
1	CytokinesIBA 12/2020
1	interleukin-21 (interleukin 21)IBA 12/2020
1	Inactivated VaccinesIBA 12/2020
1	Interleukin-6 (Interleukin 6)IBA 12/2020
1	Immunoglobulin M (IgM)IBA 01/2019
1	AerosolsIBA 01/2017
1	MVA vaccineIBA 01/2017
1	Influenza Vaccines (Influenza Vaccine)FDA Link 07/2015
1	Anthrax Vaccines (Vaccines, Anthrax)IBA 10/2014
1	QuinolonesIBA 08/2011
1	Ofloxacin (Ofloxacine)FDA LinkGeneric 08/2011
1	Moxifloxacin (Avelox)FDA Link 08/2011
1	AgarIBA 08/2011
1	fluarixIBA 08/2008
1	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 01/2004

Therapy/Procedure

3	Therapeutics 07/2022 - 07/2006
2	Noninvasive Ventilation 01/2022 - 01/2021
2	Injections 11/2021 - 01/2021
2	Intramuscular Injections 11/2021 - 01/2021
1	Artificial Respiration (Mechanical Ventilation) 01/2022